An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease-Reference-Cited by-同舟云学术

An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease

Published:2002-05-27 Issue:6 Volume:16 Page:1117-1124
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Sabate J. M.,Villarejo J.,Lemann M.,Bonnet J.,Allez M.,Modigliani R.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.2002.01273.x/fullpdf

Reference36 articles.

1. Primary and recurrent Crohn's disease. Experience with 1379 patients;Michelassi;Ann Surg,1991

2. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives;Modigliani;Gastroenterology,1990

3. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications;Rankin;Gastroenterology,1979

4. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis;Pearson;Ann Intern Med,1995

5. Methotrexate in Crohn's disease: long-term efficacy and toxicity;Lemann;Am J Gastroenterol,2000

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and risk factors of ovarian reserve decreases in women with Crohn’s disease: a case-control study;Journal of Ovarian Research;2023-02-07

2. Ovarian reserve decreases in women with Crohn's disease: clinical characteristics and risk factors-a case control study;2022-08-10

3. The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease;Frontiers in Cell and Developmental Biology;2022-05-26

4. The efficacy and safety of thalidomide in the treatment of refractory Crohn's disease in adults: a double-center, double-blind, randomized–controlled trial;Gastroenterology Report;2022-01-01

5. Thalidomide Attenuates Colitis and Is Associated with the Suppression of M1 Macrophage Polarization by Targeting the Transcription Factor IRF5;Digestive Diseases and Sciences;2021-06-03